A study for a 53 year old woman who takes Lamotrigine, Methylin - from FDA reports


Summary

95 females aged 53 (±5) who take the same drugs are studied. This is a personalized study for a 53 year old female patient who has Bipolar, Adhd. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On May, 19, 2017

95 females aged 53 (±5) who take Lamotrigine, Methylin are studied.


Number of reports submitted per year:

Lamotrigine, Methylin for a 53-year old woman.

Information of the patient in this study:

  • Age: 53
  • Gender: female
  • Conditions: Bipolar, Adhd
  • Drugs taken:
    • Lamotrigine (lamotrigine)
    • Methylin (methylphenidate hydrochloride)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • drug hypersensitivity
  • dermatitis bullous
  • appetite - decreased
  • glossodynia
  • thirst
  • dry mouth
1 - 6 months:
  • balance disorder
  • rashes
  • headache
  • abscess
  • tooth abscess
  • appetite - decreased
  • weakness
  • nausea
  • coordination abnormal
  • memory loss
6 - 12 months:
  • therapeutic response unexpected
  • suicidal ideation
  • stress and anxiety
  • pre-existing condition improved
1 - 2 years:
  • atrioventricular block complete
  • dizziness (excl vertigo)
  • chest pain
  • fatigue
  • sensation of heaviness
  • heart rate decreased
  • sick sinus syndrome
  • nausea
2 - 5 years:
  • rashes
  • arthritis
  • cataract
  • swollen tongue
  • osteopenia
  • bone disorder
  • kyphosis
  • back pain
  • disturbance in attention
  • weight decreased
5 - 10 years:
n/a
10+ years:
  • weight decreased
  • kyphosis
  • osteopenia
  • bone disorder
  • back pain
  • disturbance in attention
  • arthritis
  • cataract
  • impaired driving ability
  • psychomotor hyperactivity
not specified:
  • memory loss
  • depression
  • headache
  • back pain
  • osteopenia
  • fall
  • disturbance in attention
  • weight decreased
  • injection site pain
  • psychomotor hyperactivity

Top conditions involved for these people *:

  • Pain (11 people, 11.58%)
  • Depression (11 people, 11.58%)
  • Osteoporosis (10 people, 10.53%)
  • Narcolepsy (10 people, 10.53%)
  • Insomnia (9 people, 9.47%)

Top co-used drugs for these people *:

  • Synthroid (14 people, 14.74%)
  • Neurontin (12 people, 12.63%)
  • Flexeril (12 people, 12.63%)
  • Xanax (11 people, 11.58%)
  • Ativan (11 people, 11.58%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Methylin, Bipolar, Lamotrigine, Adhd

You may be interested in these reviews

More reviews for: Methylin, Bipolar, Lamotrigine, Adhd